PNC-27

PNC-27 is an experimental anticancer peptide that has attracted interest in cancer research because of its unique potential to target cancer cells through HDM-2, also known as MDM-2. Researchers have studied our product for its ability to interact with membrane-associated HDM-2 and disrupt cancer-cell membranes, potentially leading to cell death. Preclinical research has explored our product, across several cancer models, including pancreatic, ovarian, breast, colorectal, and leukemia cells. Its proposed mechanism distinguishes our product, from many conventional cancer therapies and makes it an interesting subject for ongoing peptide and oncology research. Learn more about our product, including its structure, proposed mechanism of action, research findings, potential applications, and current scientific status.